| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.7M | +9.8% |
| Cost of Revenue | $16.1M | +12.3% |
| Gross Profit | $3.6M | -0.3% |
| R&D Expense | $200K | +0.0% |
| SG&A Expense | $4.9M | +45.4% |
| Operating Income | -$2.0M | -235.0% |
| Net Income | -$2.5M | -68.8% |
| EPS (Basic) | -$1.01 | -1342.9% |
| EPS (Diluted) | -$1.01 | -1342.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97K | -55.9% |
| Accounts Receivable | $6.0M | +10.2% |
| Inventory | $8.7M | +2.9% |
| Current Assets | $15.1M | +3.8% |
| Total Assets | $22.5M | -12.2% |
| Current Liabilities | $10.7M | -6.3% |
| Total Liabilities | $13.9M | -6.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$172K | +86.5% |
| Investing Cash Flow | $271K | +181.9% |
| Financing Cash Flow | $132K | -85.4% |
| $8.6M |
| -20.1% |